AAAAAA
Results:
1-15
|
Results: 15
Authors:
Querenghi, F
Yu, Q
Billaud, G
Maertens, G
Trepo, C
Zoulim, F
Citation: F. Querenghi et al., Evolution of hepatitis C virus genome in chronically infected patients receiving ribavirin monotherapy, J VIRAL HEP, 8(2), 2001, pp. 120-131
Authors:
Laurent, C
Henzel, D
Mulanga-Kabeya, C
Maertens, G
Larouze, B
Delaporte, E
Citation: C. Laurent et al., Seroepidemiological survey of hepatitis C virus among commercial sex workers and pregnant women in Kinshasa, Democratic Republic of Congo, INT J EPID, 30(4), 2001, pp. 872-877
Authors:
De Meyer, S
Gong, ZJ
Hertogs, K
Depla, E
van Pelt, JF
Roskams, T
Maertens, G
Yap, SH
Citation: S. De Meyer et al., Influence of the administration of human annexin V on in vitro binding of small hepatitis B surface antigen to human and to rat hepatocytes and on invitro hepatitis B virus infection, J VIRAL HEP, 7(2), 2000, pp. 104-114
Authors:
Takaki, A
Wiese, M
Maertens, G
Depla, E
Seifert, U
Liebetrau, A
Miller, JL
Manns, MP
Rehermann, B
Citation: A. Takaki et al., Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C, NAT MED, 6(5), 2000, pp. 578-582
Authors:
Depraetere, S
Van Kerschaever, E
Vlierberghe, HV
Elewaut, A
Brouwer, JT
Niesters, HGM
Schalm, SW
Maertens, G
Leroux-Roels, G
Citation: S. Depraetere et al., Long term response to interferon treatment in chronic hepatitis C patientsis associated with a significant reduction in anti-E1 envelope antibody titers, J MED VIROL, 60(2), 2000, pp. 126-132
Authors:
Maertens, G
Priem, S
Ducatteeuw, A
Verschoorl, E
Verstrepen, B
Roskams, T
Desmet, V
Fuller, S
Van Hoek, K
Vandeponseele, P
Bosman, F
Buyse, MA
van Doorn, LJ
Heeney, J
Kos, A
Depla, E
Citation: G. Maertens et al., Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 protein, ACT GASTR B, 63(2), 2000, pp. 203-203
Characterization of small hepatitis B surface antigen epitopes involved inbinding to human annexin V
Authors:
De Meyer, S
Depla, E
Maertens, G
Soumillion, A
Yap, SH
Citation: S. De Meyer et al., Characterization of small hepatitis B surface antigen epitopes involved inbinding to human annexin V, J VIRAL HEP, 6(4), 1999, pp. 277-285
Authors:
De Meyer, S
Gong, ZJ
Depla, E
Maertens, G
Yap, SH
Citation: S. De Meyer et al., Involvement of phosphatidylserine and non-phospholipid components of the hepatitis B virus envelope in human Annexin V binding and in HBV infection in vitro, J HEPATOL, 31(5), 1999, pp. 783-790
Authors:
Gane, EJ
Maertens, G
Ducatteeuw, A
Qian, KP
Lau, JYN
Jones, H
Davies, E
Naoumov, NV
Williams, R
Citation: Ej. Gane et al., Antibodies to hepatitis C virus envelope proteins correlate with hepatitisC viraemia after liver transplantation, TRANSPLANT, 67(1), 1999, pp. 78-84
Authors:
Fournillier, A
Depla, E
Karayiannis, P
Vidalin, O
Maertens, G
Trepo, C
Inchauspe, G
Citation: A. Fournillier et al., Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralizing properties following DNA immunization, J VIROLOGY, 73(9), 1999, pp. 7497-7504
Authors:
Cramp, ME
Carucci, P
Rossol, S
Chokshi, S
Maertens, G
Williams, R
Naoumov, NV
Citation: Me. Cramp et al., Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia, GUT, 44(3), 1999, pp. 424-429
Authors:
Robertson, B
Myers, G
Howard, C
Brettin, T
Bukh, J
Gaschen, B
Gojobori, T
Maertens, G
Mizokami, M
Nainan, O
Netesov, S
Nishioka, K
Shin-i, T
Simmonds, P
Smith, D
Stuyver, L
Weiner, A
Citation: B. Robertson et al., Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization, ARCH VIROL, 143(12), 1998, pp. 2493-2503
Authors:
Alvarado-Esquivel, C
Wyseur, A
Herrera-Ortiz, FD
Ruiz-Maya, L
Ruiz-Astorga, R
Zarate-Aguilar, A
Carrillo-Maravilla, E
Herrera-Luna, R
Morales-Macedo, MD
Maertens, G
Stuyver, L
Citation: C. Alvarado-esquivel et al., Hepatitis B and C virus infections in Mexico: genotypes and geographical distribution in blood donors and patients with liver disease, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 35-41
Authors:
Van Geyt, C
De Gendt, S
Rombout, A
Wyseur, A
Maertens, G
Rossau, R
Stuyver, L
Citation: C. Van Geyt et al., A line probe assay for hepatitis B virus genotypes, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 139-145
Authors:
Stuyver, L
Fretz, C
Maertens, G
Citation: L. Stuyver et al., Strategy for hepatitis C virus genotyping in epidemiological studies, HEPATITIS C VIRUS: GENETIC HETEROGENEITY AND VIRAL LOAD, 1997, pp. 45-51
Risultati:
1-15
|